tiprankstipranks
Trending News
More News >
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
:XTLB
Advertisement

XTL Biopharmaceuticals Sponsored ADR (XTLB) Revenue

Compare
107 Followers

XTL Biopharmaceuticals Sponsored ADR Revenue

XTL Biopharmaceuticals Sponsored ADR had a revenue of 289.00K in the quarter ending Dec 31, 2024, with 78.40%. This bring the company's revenue in the last twelve months to 451.00K, Decreased 178.40%. In the fiscal year ending Dec 31, 2024, XTL Biopharmaceuticals Sponsored ADR had annual revenue of 451.00K with Infinity% growth.
Revenue (ttm)
451.00K
Revenue Growth
P/S Ratio
28.48
Revenue/Employee
$45,100
Employees
10
Market Cap
$12.85M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
451.00K+∞%
Dec 31, 2023
0.00
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis